Trethera is a clinical-stage biotechnology company advancing innovative therapies across oncology and autoimmune diseases. Our approach targets the salvage pathway, a key metabolic process that fuels diseased cell growth in cancer, autoimmune diseases, and inflammatory disorders, to disrupt disease progression and improve patient outcomes.